AAAAAA

   
Results: 1-2 |
Results: 2
IMMUNOLIPOSOMES AS ENZYME-CARRIERS (IMMUNO-ENZYMOSOMES) FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) - OPTIMIZATION OF PRODRUG ACTIVATING CAPACITY
Authors: VINGERHOEDS MH HAISMA HJ BELLIOT SO SMIT RHP CROMMELIN DJA STORM G
Citation: Mh. Vingerhoeds et al., IMMUNOLIPOSOMES AS ENZYME-CARRIERS (IMMUNO-ENZYMOSOMES) FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) - OPTIMIZATION OF PRODRUG ACTIVATING CAPACITY, Pharmaceutical research, 13(4), 1996, pp. 604-610
SURFACE MODIFICATION OF NANOPARTICLES TO OPPOSE UPTAKE BY THE MONONUCLEAR PHAGOCYTE SYSTEM
Authors: STORM G BELLIOT SO DAEMEN T LASIC DD
Citation: G. Storm et al., SURFACE MODIFICATION OF NANOPARTICLES TO OPPOSE UPTAKE BY THE MONONUCLEAR PHAGOCYTE SYSTEM, Advanced drug delivery reviews, 17(1), 1995, pp. 31-48
Risultati: 1-2 |